Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Non-academic young people take brain stimulants more frequently than students

19.03.2014

Three per cent of young men in Switzerland take cognitive enhancement drugs at least once each year.

Students hope this consumption will improve their exam performance, while their non-academic contemporaries seek primarily to remain awake for longer. These are the conclusions reached by a study supported by the Swiss National Science Foundation (SNSF).

“Brain stimulants”, “Neuroenhancers” and “Smart Pills” – the terms used for chemical-induced cognitive enhancement are numerous. While these substances are actually intended for use in the treatment of attention disorders, Alzheimer's and Parkinson's, they are often taken for other purposes. In the USA, one in every 20 students uses drugs such as Ritalin or Prozac at least once a year, despite not actually suffering from an attention deficit disorder or from depression. What is the situation in Switzerland?

Less than in the USA

... more about:
»Ritalin »SNF »cognitive »disorders »drugs »substances

Researchers led by Gerhard Gmel at the University Hospital Lausanne (CHUV) surveyed young men called up for conscription to the army recruitment centres in Lausanne, Windisch and Mels, on the frequency of and reasons for their use of cognitive enhancers. In a recently published evaluation (*), the researchers find that the use of cognitive enhancers in Switzerland is less prevalent than in the USA; only 180 of 5,967 participants in the study (around three per cent) had used brain-stimulating drugs at least once in the previous year.

Exams and partying

The researchers detected large differences between students and non-academics of the same age. On average, students take various cognitive enhancers five times a year. Their primary aim is to improve performance, for example in exams. Their non-academic contemporaries take drugs almost weekly, or around 40 times a year on average; most use Ritalin and other drugs that are prescribed for attention disorders. Their main motivation is to remain awake for longer, at parties, for example.

New prevention strategies

Gmel and his team believe the new figures reveal a need to widen the focus of studies into the consumption of cognitive enhancers. So far, attention has been primarily oriented towards (US-based) students. However, in Switzerland cognitive enhancers are being used to a greater extent by non-academics, for whom new prevention strategies will need to be developed.

(*) Stéphane Deline, Stéphanie Baggio, Joseph Studer, Alexandra N’Goran, Marc Dupuis, Yves Henchoz, Meichun Mohler-Kuo, Jean-Bernard Daeppen and Gerhard Gmel (2014). Use of Neuroenhancement Drugs: Prevalence, Frequency and Use Expectations in Switzerland. International Journal of Environmental Research and Public Health 11: 3032-3045
(Available to journalists as a PDF file from the SNSF at the following e-mail address: com@snf.ch)

The C-Surf cohort study

Consumption of addictive substances among juveniles and young adults living in Switzerland is more frequent on average than in other European countries. The Cohort Study on Substance Use Risk Factors (C-Surf) is looking into the reasons and opportunities for prevention. With funding from the Swiss National Science Foundation (SNSF), and under the leadership of the University Hospital Lausanne (Centre hospitalier universitaire vaudois, CHUV) and the Institute for Social and Preventive Medicine (ISPM) at the University of Zurich, C-Surf studies young men over a period of at least ten years.
http://www.c-surf.ch

Contact
Dr Gerhard Gmel
Alcohol Treatment Centre
University Hospital Lausanne (CHUV)
CH-1011 Lausanne
Phone: +41 21 321 29 59
+41 21 314 73 52
E-mail: Gerhard.Gmel@chuv.ch

This press release can be found on the website of the Swiss National Science Foundation.

Weitere Informationen:

http://www.snf.ch/en/researchinFocus/newsroom/Pages/news-140319-mm-brain-stimula...

Media - Abteilung Kommunikation | idw - Informationsdienst Wissenschaft

Further reports about: Ritalin SNF cognitive disorders drugs substances

More articles from Studies and Analyses:

nachricht Researchers simplify tiny structures' construction drip by drip
12.11.2018 | Princeton University, Engineering School

nachricht Mandibular movement monitoring may help improve oral sleep apnea devices
06.11.2018 | Elsevier

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>